8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2020 / Controlled feeding studies
Volunteers consumed either a 60% kcal fat meal (n=98) or a 36% kcal fat meal (n=62, placebo group). At least 87.5% of plasma LPS measurements in 32 tested participants were below the assay sensitivity (0.002 EU/mL). Although polymyxin B suppressed IL-1β (P = 0.035) and IL-6 (P = 0.0487) production in 3 h postprandial blood after 24 h incubation in the 60% fat study, the LPS present did not increase cytokine concentrations above fasting levels. In vitro lipoprotein lipase treatment significantly increased FFA and cytokine concentrations (P < 0.05) in both studies.
Mo Z, Huang S, Burnett DJ, et al. J Nutr, 2020. PMID 32040591
2020 / Intervention trial with matched controls
Adult-onset mitochondrial myopathy patients and matched controls received increasing doses of the vitamin B3 form niacin (up to 750-1,000 mg/day) for 10 or 4 months, respectively. Blood NAD+ increased in all subjects up to 8-fold, and muscle NAD+ in patients reached control levels. Muscle strength and mitochondrial biogenesis increased in all subjects, patients' muscle metabolomes shifted toward controls, and liver fat decreased by as much as 50%, though some patients showed an anemia tendency.
Pirinen E, Auranen M, Khan NA, et al. Cell Metab, 2020. PMID 32386566
2020 / Randomized double-blind placebo-controlled trial
Fifty patients with migraine were randomized to receive either cinnamon powder (three capsules/day, each containing 600 mg) or placebo (three capsules/day of corn starch) for 2 months. Compared with the control group, serum concentrations of IL-6 and NO were significantly reduced in the cinnamon group (p < .05), while CGRP levels remained unchanged in both groups. In addition, the frequency, severity, and duration of migraine attacks significantly decreased in the cinnamon group compared to controls.
Zareie A, Sahebkar A, Khorvash F, et al. Phytother Res, 2020. PMID 32638445
2019 / Parallel randomized clinical trial
A parallel randomized clinical trial evaluated the effect of consuming 240 ml of soy milk daily as part of a 500-calorie deficit diet compared to the deficit diet alone for 8 weeks in 70 patients with NAFLD. The soy milk group showed significantly greater reductions in serum alanine aminotransferase (-12.06 ± 17.61 IU/L vs. -5 ± 8.58 IU/L, p = 0.04) and hs-CRP (-1.32 ± 1.60 mg/L vs. -0.36 ± 1.54 mg/L, p = 0.01). However, changes in fatty liver grade, other liver enzymes (AST, ALP, GGT), lipid profiles, and anthropometric indices did not differ significantly between groups.
Eslami O, Shidfar F, Maleki Z, et al. J Am Coll Nutr, 2019. PMID 30028245
2019 / Randomized controlled trial
In an 8-week randomized trial of 40 adolescent boys with active nonalcoholic fatty liver disease, restricting free sugars to under 3% of daily calories reduced hepatic steatosis from 25% to 17%, compared with 21% to 20% in the usual diet group (adjusted mean difference -6.23%; 95% CI, -9.45% to -3.02%; P < .001). Alanine aminotransferase levels decreased more with the low-sugar diet (adjusted ratio of geometric means 0.65; 95% CI, 0.53 to 0.81; P < .001). Seven secondary outcomes were null.
Schwimmer JB, Ugalde-Nicalo P, Welsh JA, et al. JAMA, 2019. PMID 30667502
2019 / Randomized, double-blind trial
In a randomized, double-blind trial, adults aged 45 to 79 with symptomatic knee osteoarthritis consumed either 40 g of freeze-dried blueberry powder (n = 33) or placebo powder (n = 30) daily for four months. The blueberry group experienced significant decreases in WOMAC total score, pain, stiffness, and difficulty performing daily activities (p < 0.05), whereas improvements in total score and daily activities were not seen with placebo. In the blueberry group, normal walking pace single support percentage increased for both limbs (p ≤ 0.007) and double support percentage decreased (p ≤ 0.003). No significant changes were observed in plasma concentrations of TNF-α, IL-1β, IL-6, IL-10, IL-13, MMP-3, MMP-13, and MCP-1 in either group, though trends were observed for IL-13 and MCP-1 in the blueberry group.
Du C, Smith A, Avalos M, et al. Nutrients, 2019. PMID 30699971
2019 / Randomized crossover trial
In a randomized crossover study of obese adults with type 2 diabetes, acute raspberry intake lowered postprandial serum glucose at two and four hours and decreased IL-6 and hsTNF-alpha at four hours (p < 0.05). Following four weeks of daily supplementation, IL-6 and hsTNF-alpha remained significantly reduced compared to control periods (p < 0.05). The intervention did not alter fasting blood sugar, blood lipids, C-reactive protein, or vascular elasticity.
Schell J, Betts NM, Lyons TJ, et al. Ann Nutr Metab, 2019. PMID 30763939
2019 / Randomized controlled clinical trial
Fifty-five obese women without baseline selenium deficiency were randomly assigned to consume 1 unit/d of Brazil nuts (~1261 μg/Se) or no intervention for 2 months. In the Brazil nut group, all selenium biomarkers and the gene expression of proinflammatory parameters (interleukin-6, tumor necrosis factor-α, and Toll-like receptors 2 and 4) increased significantly (P < 0.05). No changes occurred in the control group. While plasma inflammatory biomarker levels did not change, the authors concluded that the increased gene expression may indicate a proinflammatory stimulus induced by high-selenium Brazil nut consumption in obesity.
Duarte GBS, Reis BZ, Rogero MM, et al. Nutrition, 2019. PMID 31026738
2019 / Two-phase double-blind randomized clinical trial
A two-phase, double-blind randomized clinical trial evaluated the effects of consuming a flavonoid-rich cocoa beverage daily for up to 12 weeks. In the initial study (60 subjects aged 55-70), the flavonoid-rich group showed improvements in glycemia, triglyceridemia, HDL, LDL, the triglyceridemia/HDL index, oxidative markers, the Up and Go test, skeletal muscle index, and quality of life compared to placebo or non-flavonoid cocoa. In the follow-up study (74 subjects aged 65-90), flavonoid treatment significantly improved metabolic, oxidative stress, and inflammatory endpoints, along with positive effects on physical performance, frailty indicators, and quality of life compared with the non-flavonoid beverage.
Munguia L, Rubio-Gayosso I, Ramirez-Sanchez I, et al. J Gerontol A Biol Sci Med Sci, 2019. PMID 31056655
2019 / Randomized, parallel, controlled trial
Sixty-six patients with NAFLD were randomly assigned to a 500-calorie deficit diet either with or without 240 ml/day of soy milk for 8 weeks. Compared to the control group, the soy milk group showed significantly greater reductions in serum insulin (-3.44 ± 5.02 vs. -1.09 ± 3.77 μIU/ml, P = 0.04), HOMA-IR (-0.45 ± 0.64 vs -0.14 ± 0.47, P = 0.03), systolic BP (-3.81 ± 4.15 vs -1.48 ± 2.93 mmHg, P = 0.01), and diastolic BP (-2.39 ± 2.80 vs. -0.94 ± 2.76 mmHg, P = 0.04), plus a significant increase in QUICKI (0.02 ± 0.032 vs. 0.008 ± 0.018, P = 0.04). Changes in fasting blood sugar, HOMA-β%, fibrinogen, and malondialdehyde did not differ significantly between groups.
Maleki Z, Jazayeri S, Eslami O, et al. Complement Ther Med, 2019. PMID 31126574
2019 / Randomized crossover trial
Seventeen healthy young subjects consumed a high-fat meal (HFM) along with water, fruit juice, or champagne in a randomized crossover design. Across the whole group, the HFM caused significant hypertriglyceridemia (from 0.77 ± 0.07 to 1.41 ± 0.18 mmol/L, p < 0.001) without overall impairment of FMD. However, in 10 subjects where HFM decreased FMD (from 10.73 ± 0.95 to 8.1 3± 0.86 and 8.07 ± 1.16%; p < 0.05 and p < 0.01 at 2 and 3 hours, respectively), FMD did not decrease when drinking juice or champagne. The authors concluded that fruit juice or champagne might reduce such alterations, though further studies are needed to determine the mechanisms.
Rouyer O, Auger C, Charles AL, et al. J Clin Med, 2019. PMID 31208093
2019 / Single-arm pilot intervention trial
Seventeen women aged 20 to 45 with Hashimoto's thyroiditis participated in a 10-week online health coaching program implementing the Autoimmune Protocol elimination diet. Among the 16 women who completed questionnaires, statistically significant improvements were observed across all eight SF-36 subscales, and the MSQ symptom burden decreased from an average of 92 (SD 25) to 29 (SD 20). High-sensitivity C-reactive protein (n = 14) decreased significantly by 29% (p = 0.0219), from 1.63 mg/L (SD 1.72) to 1.15 mg/L (SD 1.31). No statistically significant changes were observed in thyroid function tests or thyroid antibodies.
Abbott RD, Sadowski A, Alt AG Cureus, 2019. PMID 31275780
2019 / Pilot study
A pilot study evaluated the postprandial effects of high-fat/high-glycemic load meals enriched with blueberries in 5 obese/overweight patients with metabolic syndrome. Significant decreases in urinary methylamines, acetoacetate, acetone, and succinate were observed at 2 and 4 hours post-ingestion, alongside accumulation of gut-derived phenolic acids. In mononuclear blood cells, mRNA expression of interleukin-6 significantly decreased and transforming growth factor-β significantly increased following blueberry supplementation.
Sobolev AP, Ciampa A, Ingallina C, et al. Metabolites, 2019. PMID 31295937
2019 / Randomized clinical trial
In this randomized clinical trial, 43 patients with type 2 diabetes and chronic periodontitis were randomly allocated to receive resveratrol supplements or placebo for 4 weeks alongside non-surgical periodontal therapy. In the intervention group, the mean serum level of IL6 decreased significantly post-intervention from 2.19 ± 1.09 to 1.58 ± 1.06 (P = 0.039). However, no significant differences were observed between the intervention and control groups post-intervention for IL6, TNFα, TAC, or CAL.
Javid AZ, Hormoznejad R, Yousefimanesh HA, et al. Diabetes Metab Syndr, 2019. PMID 31405706
2019 / Placebo-controlled, randomized, double-blind, crossover trial
In a randomized, double-blind, placebo-controlled crossover study, 12 aged men received 1 g per day of oral nicotinamide riboside (NR) or placebo for 21 days. Targeted metabolomics demonstrated that NR increased the muscle NAD+ metabolome, as shown by higher nicotinic acid adenine dinucleotide and nicotinamide clearance products. Muscle RNA sequencing showed downregulation of energy metabolism and mitochondrial pathways, though mitochondrial bioenergetics were not altered. Additionally, NR supplementation reduced circulating inflammatory cytokine levels.
Elhassan YS, Kluckova K, Fletcher RS, et al. Cell Rep, 2019. PMID 31412242
2019 / Randomized crossover trial
In a randomized crossover study, 24 healthy adult males consumed a high-fat breakfast with or without 50 g of freeze-dried mango pulp. At 1 hour post-meal, mango consumption resulted in significantly lower glucose (95.8 ± 4.4 mg/dL vs. 104.8 ± 5.4 mg/dL; P = .002) and higher HDL-C (58.4 ± 2.7 mg/dL vs. 55.2 ± 2.3 mg/dL; P = .01). However, no significant meal × time interactions were observed for triglycerides (P = .88), inflammatory markers (C-reactive protein, P = .17; interleukin-6, P = .30), or antioxidant enzymes (superoxide dismutase, P = .77; glutathione peroxidase, P = .36; catalase, P = .32).
O'Hara C, Ojo B, Emerson SR, et al. Nutr Metab Insights, 2019. PMID 31452602
2019 / Randomized, double-blind, placebo-controlled pilot study
A randomized, double-blind, placebo-controlled pilot study evaluated 60 overweight adults with symptomatic knee osteoarthritis assigned to 600 mg of non-animal chondroitin sulfate (CS) daily or placebo for 12 weeks. The experimental group showed a significant increase in Tegner Lysholm Knee Scoring (+10.64 points; 95% CI 5.57, 15.70; p < 0.01) and a decrease in WOMAC score (-12.24 points; 95% CI -16.01, -8.38; p < 0.01). Significant decreases were also seen in C-reactive protein (-0.14 mg/dL; 95% CI -0.26, -0.04; p < 0.01), erythrocyte sedimentation rate (-5.01 mm/h; 95% CI -9.18, -0.84; p < 0.01), and visual analogue scale pain scores in both knees.
Rondanelli M, Braschi V, Gasparri C, et al. Nutrients, 2019. PMID 31470599
2019 / Randomized crossover trial
In a randomized crossover trial of 11 healthy subjects adhering to 2-week low-salt and high-salt diets, salt increased monocyte expression of the chemokine receptor CCR2. A high-salt diet also increased plasma MCP-1, transendothelial monocyte migration, and skin macrophage density. In addition, macrophages displayed an elevated proinflammatory phenotype, including increased in vitro cytokine secretion of IL-6, TNF, and IL-10, as well as increased skin macrophage HLA-DR expression.
Wenstedt EF, Verberk SG, Kroon J, et al. JCI Insight, 2019. PMID 31672939
2018 / Double-blind, crossover, randomized, placebo-controlled trial
In a randomized, double-blind crossover trial, 22 older adults with abdominal obesity underwent a 6-hour oral fat tolerance test after consuming either a supplement (200 mg resveratrol and 100 mg curcumin) or a placebo. Supplementation did not modify postprandial variations in circulating inflammatory markers (CRP, IL-6, IL-8, MCP-1) or adhesion molecules (sE-selectin, sVCAM-1, sICAM-1) compared to placebo (P Treatment×Time > 0.05). However, the supplement significantly reduced the cumulative postprandial response of sVCAM-1 (incremental area under the curve -4643%, P = 0.01), while whole-blood PPARA and NFKB1 gene expressions were unchanged.
Vors C, Couillard C, Paradis ME, et al. J Nutr, 2018. PMID 29546309
2018 / Double-blind, randomized crossover trial
A double-blind, randomized crossover trial evaluated the effects of 16 mg daily of TA-65 (an Astragalus membranaceus extract) versus placebo for 12 weeks with a 3-week washout in 40 patients with metabolic syndrome. Compared to placebo, TA-65 treatment led to significantly higher HDL-C and lower BMI, waist circumference, LDL/HDL ratio, and plasma TNF-alpha (p < 0.05 for all). Changes in HDL-C between periods were negatively correlated with changes in CRP (r = -0.511, p < 0.01), ALT (r = -0.61, p < 0.001), and TNF-alpha (r = -0.550, p < 0.001).
Fernandez ML, Thomas MS, Lemos BS, et al. Curr Pharm Des, 2018. PMID 29546832
2018 / Randomized controlled trial
Twenty men with metabolic syndrome received either autologous or lean vegan-donor fecal transplants. After two weeks, vegan-donor transplants altered microbial community structure toward a vegan profile in some participants. However, the intervention caused no functional changes in TMAO synthesis from choline or carnitine, aortic radiotracer uptake, or cytokine generation from isolated immune cells.
Smits LP, Kootte RS, Levin E, et al. J Am Heart Assoc, 2018. PMID 29581220
2018 / Randomized controlled trial
Forty adults with mild to moderate nonalcoholic fatty liver disease were randomized to consume ancient KAMUT khorasan or modern wheat products for 3 months. Compared with baseline, the khorasan group had significant reductions in alanine aminotransferase by 12%, aspartate aminotransferase by 14%, alkaline phosphatase by 8%, and cholesterol by 6% (all p < 0.05). Proinflammatory cytokines decreased significantly only with khorasan, while steatosis grading and reactive oxygen species improved in both study groups.
Dinu M, Whittaker A, Pagliai G, et al. J Am Coll Nutr, 2018. PMID 29652567
2018 / Controlled feeding trial
In a controlled clinical trial, 38 overweight adults received 1,000 extra kcal per day from saturated fat, unsaturated fat, or simple sugars for 3 weeks. Intrahepatic triglyceride levels increased by 55% with saturated fat and by 15% with unsaturated fat (P < 0.05), compared to 33% with simple sugars. Saturated fat overfeeding also elevated lipolysis, insulin resistance, endotoxemia, and plasma ceramides.
Luukkonen PK, Sädevirta S, Zhou Y, et al. Diabetes Care, 2018. PMID 29844096
2018 / Secondary analysis of a trial (before-and-after / paired analysis)
In a secondary analysis of a trial, 31 overweight and obese adults with LDL cholesterol >100 mg/dL consumed a defined plant-based diet for 4 weeks. Significant reductions were observed for serum Lp(a) (-32.0 ± 52.3 nmol/L, P = 0.003), apolipoprotein B (-13.2 ± 18.3 mg/dL, P < 0.0005), LDL particles (-304.8 ± 363.0 nmol/L, P < 0.0005), and small-dense LDL cholesterol (-10.0 ± 9.2 mg/dL, P < 0.0005). Significant reductions were also seen in IL-6, total white blood cells, Lp-PLA2, hs-CRP, and fibrinogen (all P ≤ 0.004).
Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 30014498